What is DXCM's market capitalization?

DexCom has a market capitalization of $28.40B.

Does DXCM pay a dividend?

DexCom does not currently pay a dividend, or dividend data is unavailable. Many growth-oriented companies reinvest profits rather than paying dividends.

What is DXCM's earnings per share (EPS)?

DexCom's trailing twelve-month earnings per share (EPS) is $1.40. EPS measures the portion of company profit allocated to each outstanding share of stock.

DXCM

NASDAQ

DexCom

Price unavailable — configure POLYGON_API_KEY

Overview Earnings Dividends IR

Key Statisticslimited data

Market Cap$28.40B

P/E RatioN/A

Div. Yield—

EPS (TTM)$1.40

52W High—

52W Low—

SectorHealth Care

Industry—

Employees11,100

Price Performance

1 Week-0.05%

3 Month-8.03%

1 Year+0.68%

FinancialsAnnual · QuiverQuant

Revenue$3.62B

Assets$6.26B

Liabilities$4.20B

Net Income$541.50M

About

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Company Info

SAN DIEGO, CA

11,100 employees

Listed 2005-04-14

surgical & medical instruments & apparatus

www.dexcom.com

📞(858) 200-0200

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account

Analyze DXCM with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.